NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ultragenyx and certain of its officers and/or […]

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP is investigating claims on behalf of investors of AppLovin Corporation ("AppLovin" or the "Company") (NASDAQ:APP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether AppLovin and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ:ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zenas and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Atlassian Corporation ("Atlassian" or the "Company") (NASDAQ:TEAM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Atlassian and certain of its officers and/or directors

This broadcast airs as sponsored programming and includes television commercials from NeOnc Technologies (NASDAQ:NTHI), Synergy CHC (NASDAQ:SNYR), DataVault AI (NASDAQ:DVLT), and The Sustainable Green Team (OTCQB:SGTM). NEW YORK CITY, NEW YORK / ACCESS Newswire / January 31, 2026 / New to The Street airs today on Bloomberg Television across the United States, the Middle East

NEW YORK, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Bgin Blockchain Limited ("Bgin" or the "Company") (NASDAQ:BGIN).��Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com�or 646-581-9980, ext.�7980. The investigation concerns whether Bgin and certain of its officers and/or directors have engaged in

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Sigma Lithium Corporation ("Sigma Lithium" or the "Company") (NASDAQ:SGML). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sigma Lithium and certain of its

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Oracle Corporation ("Oracle" or the "Company") (NYSE:ORCL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Oracle and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Navan, Inc. ("Navan" or the "Company") (NASDAQ:NAVN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Navan and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ:BBNX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Beta Bionics and certain of its